Verona Pharma plc (I9SA) — Cash Flow Reinvestment Rate
Latest as of June 2025:
0.00x
Verona Pharma plc (I9SA) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting €0.00 (capex €0.00 ) from operating cash flow of €30.56 Million. Check I9SA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
€0.00
Capex + Investments
Operating Cash Flow
€30.56 Million
EUR
Capital Expenditures
€0.00
EUR
Annual Cash Flow Reinvestment Rate for Verona Pharma plc (None–None)
Year-by-year capital reinvestment analysis for Verona Pharma plc. For live market cap and broader valuation context, see Verona Pharma plc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow